← Leaderboards
Michael T Yin
Columbia University Health Sciences
$11,180,339
Attributed
$20,048,564
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,048,564 · 11
By mechanism
R01$11,327,671 · 4
R61$2,999,059 · 1
UH3$2,500,594 · 1
R21$973,018 · 2
K24$939,620 · 1
UG3$661,682 · 1
Top collaborators
- Stephen M Arpadi7 shared
- Sunil Wadhwa6 shared
- David A Albert5 shared
- Peter Gregory Gordon5 shared
- Sara Hurtado Bares3 shared
- Rosa Maria Affonso Moyses3 shared
- Zizhang Sheng3 shared
- Xueling Wu3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David A Albert$1,573,187
- Peter Gregory Gordon$1,054,092
- Sara Hurtado Bares$1,225,525
- Elsa-Grace G Giardina$628,156
Others in their field
Top investigators on “Antiretroviral Therapy”
- James Dennis Neaton · Northwestern University$279,044,427
- Lawrence Corey · Fred Hutchinson Cancer Center$278,220,635
- Constance Ann Benson · University Of California, San Diego$241,336,455
- Carol Nesel · Westat$188,148,170
- Judith S. Currier · University Of California Los Angeles$182,467,520
- Barbara Driver · Westat, Inc.$170,789,549
Research focus
Antiretroviral TherapyHiv InfectionsWomanFractureBone LossSkeletalOsteoporosisPathway InteractionsPostmenopauseBone DensityBoneInflammationFuturePersonsSerumPreventWomen&AposResearch PersonnelDesignBone MetabolismPrevalenceOsteoblastsBone MassCytokine
Grant awards (42)
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility$994,203
R61 · FY2025 · AI
Effectiveness of comprehensive ETE interventions in the dental settingÂ$836,740
UH3 · FY2025 · DE · contact PI
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)$649,784
R01 · FY2025 · AG · contact PI
Mentoring Research in Non-infectious Complications of HIV$186,455
K24 · FY2025 · AI · contact PI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility$1,002,428
R61 · FY2024 · AI
Effectiveness of comprehensive ETE interventions in the dental settingÂ$795,516
UH3 · FY2024 · DE · contact PI
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)$677,556
R01 · FY2024 · AG · contact PI
Mentoring Research in Non-infectious Complications of HIV$186,995
K24 · FY2024 · AI · contact PI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility$1,002,428
R61 · FY2023 · AI
Effectiveness of comprehensive ETE interventions in the dental settingÂ$868,338
UH3 · FY2023 · DE · contact PI
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)$797,940
R01 · FY2023 · AG · contact PI
Impact of HIV and antiretroviral initiation on skeletal biology$187,884
R21 · FY2023 · TW · contact PI
Mentoring Research in Non-infectious Complications of HIV$186,995
K24 · FY2023 · AI · contact PI
Impact of HIV and antiretroviral initiation on skeletal biology$100,000
R21 · FY2023 · TW · contact PI
Effectiveness of comprehensive ETE interventions in the dental settingÂ$326,989
UG3 · FY2022 · DE · contact PI
Impact of HIV and antiretroviral initiation on skeletal biology$245,134
R21 · FY2022 · TW · contact PI
Mentoring Research in Non-infectious Complications of HIV$188,591
K24 · FY2022 · AI · contact PI
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women$448,486
R01 · FY2021 · DE · contact PI
Effectiveness of comprehensive ETE interventions in the dental settingÂ$334,693
UG3 · FY2021 · DE · contact PI
Mentoring Research in Non-infectious Complications of HIV$190,584
K24 · FY2021 · AI · contact PI
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women$443,800
R01 · FY2020 · DE · contact PI
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women$456,341
R01 · FY2019 · DE · contact PI
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women$440,939
R01 · FY2018 · DE · contact PI
Biological aging in older HIV-infected African Americans$240,000
R21 · FY2018 · AG
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women$102,481
R01 · FY2018 · DE · contact PI
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women$452,013
R01 · FY2017 · DE · contact PI
Biological aging in older HIV-infected African Americans$200,000
R21 · FY2017 · AG
Bone health in perinatally HIV-infected South African children on antiretrovirals$716,877
R01 · FY2016 · HD
Bone health in perinatally HIV-infected South African children on antiretrovirals$691,417
R01 · FY2015 · HD
HIV and the menopausal transition: effects on musculoskeletal health$580,465
R01 · FY2015 · AI · contact PI
Bone health in perinatally HIV-infected South African children on antiretrovirals$664,924
R01 · FY2014 · HD
HIV and the menopausal transition: effects on musculoskeletal health$632,003
R01 · FY2014 · AI · contact PI
Bone health in perinatally HIV-infected South African children on antiretrovirals$690,382
R01 · FY2013 · HD
HIV and the menopausal transition: effects on musculoskeletal health$623,344
R01 · FY2013 · AI · contact PI
Bone health in perinatally HIV-infected South African children on antiretrovirals$815,535
R01 · FY2012 · HD
HIV and the menopausal transition: effects on musculoskeletal health$663,132
R01 · FY2012 · AI · contact PI
HIV and the menopausal transition: effects on musculoskeletal health$780,252
R01 · FY2011 · AI · contact PI
Bone mass and mineral metabolism in HIV+ women$129,384
K23 · FY2008 · AI · contact PI
Bone mass and mineral metabolism in HIV+ women$129,384
K23 · FY2007 · AI · contact PI
Bone mass and mineral metabolism in HIV+ women$129,384
K23 · FY2006 · AI · contact PI
Bone mass and mineral metabolism in HIV+ women$129,384
K23 · FY2005 · AI
Bone mass and mineral metabolism in HIV+ women$129,384
K23 · FY2004 · AI